Walfs Pharma Private Limited - Company Profile

It is a pharma private limited company based in Perambur Purasawalkam, Tamil Nadu, India, established in 2023.
2023 Perambur Purasawalkam, Tamil Nadu, India Active
Last Updated:
Access Report
About Walfs Pharma Private Limited

Walfs Pharma Private Limited, a active private limited company, was established on 27 March 2023 in Perambur Purasawalkam, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U21003TN2023PTC159158. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.

Its leadership includes Mahalingam Ramanan (Director), Ramanan Uma Mageswari (Director), Gorav Gupta (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No 78, Perambur High Road, Perambur, Perambur Purasawalkam, Tamil Nadu, 600011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21003TN2023PTC159158

  • Registration Number

    159158

  • Incorporation Date

    27 March 2023

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 2 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Walfs Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Walfs Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Walfs Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahalingam Ramanan Director 27 Mar 2023 Current
Ramanan Uma Mageswari Director 27 Mar 2023 Current
Gorav Gupta Director 27 Mar 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Walfs Pharma.

Enhance accessibility to Walfs Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Walfs Pharma revenue growth over time
Walfs Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Walfs Pharma?

Unlock access to Walfs Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Walfs Pharma?

Unlock and access historical data on people associated with Walfs Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Walfs Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walfs Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Walfs Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Walfs Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Walfs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Director Appointment

    Mahalingam Ramanan was appointed as a Director was appointed as a Director on 27 Mar 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Director Appointment

    Ramanan Uma Mageswari was appointed as a Director was appointed as a Director on 27 Mar 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Director Appointment

    Gorav Gupta was appointed as a Director was appointed as a Director on 27 Mar 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Company Incorporation

    The activity Walfs Pharma Private Limited was registered on 27 Mar 2023 with Roc Chennai & aged 2 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Walfs Pharma Private Limited?

The CIN of Walfs Pharma Private Limited is U21003TN2023PTC159158.

Where is Walfs Pharma Private Limited headquartered?

Walfs Pharma Private Limited is headquartered at No 78, Perambur High Road, Perambur, Perambur Purasawalkam, Tamil Nadu, 600011.

When was Walfs Pharma Private Limited incorporated?

Walfs Pharma Private Limited was incorporated on 27 March 2023.

Who are the current directors of Walfs Pharma Private Limited?

The current directors of Walfs Pharma Private Limited are

What is the primary industry of Walfs Pharma Private Limited?

The primary industry of Walfs Pharma Private Limited is Pharma.

Is Walfs Pharma Private Limited a listed company?

Walfs Pharma Private Limited is unlisted.

What is the capital structure of Walfs Pharma Private Limited?

The authorized capital of Walfs Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available